Loading
No insider purchase over the last 90 days. The latest, by Hasmoro, was filed 02 Dec 2025.
PT Medikaloka Hermina Tbk. is a listed company. Filings by its managers are published through OJK / IDX. In the past year (24 October 2025 to 24 October 2026), 1 filing came from 1 insider.
No insider sold shares on the market over the period. Instead, the filings list 1 purchase totalling €89k, made by 1 insider. Unlike grants, an open-market purchase is paid for by the insider, at the market price. On the buying side, the filings list 1 board member among the declarants. The largest single trade was a purchase of €89k by Hasmoro, published on 2 December 2025.
Compared with its exchange (301 companies, median 3 filings), a count of 1 filing is below the norm. Since 2023, the database holds 28 purchases and no sales by insiders of the company.
The last insider purchase was made public on 2 December 2025, 325 days ago.
This summary is built from OJK / IDX disclosures alone and does not predict where the share price will go.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
25 of 28 declarations
PT Medikaloka Hermina Tbk. is an Indonesian company specializing in healthcare services, including the management of hospitals and clinics. It is listed on the Indonesia Stock Exchange (XIDX).